市場調査レポート

商品コード

1134164

閉鎖式薬物移送システム（CSTD）の世界市場：2027年までの予測

Global Closed System Drug Transfer Device (CSTD) Market Research Report - Forecast till 2027

出版日: 2022年10月03日 | 発行: Market Research Future

| ページ情報: 英文 110 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,950 771,457円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。

PDF (Multi User License)

USD 5,950 927,307円

レポートPDFを同一企業内の最大10名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。

PDF (Enterprise License)

USD 7,250 1,129,912円

レポートPDFを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.85円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の閉鎖式薬物移送システム（CSTD）の市場規模は、2027年までの調査期間中に19.10%のCAGRで成長し、2027年には89億5,000万米ドルに達すると予測されています。本来あるべき形でない、あるいは意図したとおりに機能していない臨床用機器の多さは、閉鎖式薬物移送システム（CSTD）市場の成長を抑制していると考えられます。

当レポートでは、世界の閉鎖式薬物移送システム（CSTD）市場について調査分析し、市場力学、市場分析、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

イントロダクション
促進要因
- がん症例の有病率の上昇
- 医療従事者の有害薬物への暴露の増加
- 閉鎖式薬物移送システム（CSTD）の使用に関するいくつかの安全ガイドラインと法律
抑制要因
- 高コスト
- 閉鎖式薬物移送システム（CSTD）の使用に関するFDAによる有害事象および法的な警告
機会
- 閉鎖式薬物移送システム（CSTD）の新興市場

第5章市場要因分析

ポーターのファイブフォース分析
- 供給企業の交渉力
- 買い手の交渉力
- 新規参入業者の脅威
- 代替品の脅威
- 競争の激しさ
サプライチェーン分析
- 研究開発
- 製造
- 流通
- マーケティング販売
- 販売後のモニタリング
投資機会
価格分析
マーケティングチャネル
- 直接マーケティング
- 間接マーケティング
規制業務
生産コスト分析
- 原材料コスト分析
- 技術コスト分析
- 人件費分析

第6章閉鎖式薬物移送システム（CSTD）市場：タイプ別

概要
- イントロダクション
- バリア式
- ろ過式

第7章閉鎖式薬物移送システム（CSTD）市場：送達別

概要
- イントロダクション
- クローズドバッグ/ラインアクセスデバイス
- クローズドバイアルアクセスデバイス
- クローズドシリンジセーフティデバイス

第8章閉鎖式薬物移送システム（CSTD）市場：エンドユーザー別

概要
- イントロダクション
- 専門センター
- 病院とクリニック

第9章世界の閉鎖式薬物移送システム（CSTD）市場：地域別

イントロダクション
南北アメリカ
- 北米
- 南米
欧州
- 西欧
- 西欧
- 東欧
アジア太平洋
- 中国
- インド
- 日本
- オーストラリア
- 韓国
- インドネシア
- その他のアジア太平洋地域
中東とアフリカ
- 中東
- アフリカ

第10章競合情勢

イントロダクション
主な開発

第11章企業プロファイル

BECTON, DICKINSON AND COMPANY
TEVA PHARMACEUTICAL INDUSTRIES LTD
EQUASHIELD LLC
ICU MEDICAL INC
YUKON MEDICAL
CORVIDA MEDICAL

第12章付録

ディスカッションの洞察

図表

LIST OF TABLES

TABLE 1 PRIMARY INTERVIEWS 17
TABLE 2 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 34
TABLE 3 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR BARRIER-TYPE, BY REGION, 2020-2027 (USD MILLION) 35
TABLE 4 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR FILTRATION-TYPE, BY REGION, 2020-2027 (USD MILLION) 35
TABLE 5 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 38
TABLE 6 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR CLOSED BAG/LINE ACCESS DEVICES, BY REGION, 2020-2027 (USD MILLION) 39
TABLE 7 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR CLOSED VIAL ACCESS DEVICES, BY REGION, 2020-2027 (USD MILLION) 39
TABLE 8 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR CLOSED SYRINGE SAFETY DEVICES, BY REGION, 2020-2027 (USD MILLION) 40
TABLE 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2020-2027 (USD MILLION) 43
TABLE 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR SPECIALTY CENTERS, BY REGION, 2020-2027 (USD MILLION) 43
TABLE 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2027 (USD MILLION) 44
TABLE 12 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2020-2027 (USD MILLION) 47
TABLE 13 AMERICAS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2020-2027 (USD MILLION) 48
TABLE 14 AMERICAS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 49
TABLE 15 AMERICAS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 49
TABLE 16 AMERICAS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 50
TABLE 17 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 50
TABLE 18 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 51
TABLE 19 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 51
TABLE 20 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 52
TABLE 21 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 52
TABLE 22 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 53
TABLE 23 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 53
TABLE 24 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 54
TABLE 25 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 54
TABLE 26 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 55
TABLE 27 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 55
TABLE 28 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 55
TABLE 29 SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 56
TABLE 30 SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 56
TABLE 31 SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 57
TABLE 32 BRAZIL: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 57
TABLE 33 BRAZIL: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 57
TABLE 34 BRAZIL: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 58
TABLE 35 REST OF SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 58
TABLE 36 REST OF SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 59
TABLE 37 REST OF SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 59
TABLE 38 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2020-2027 (USD MILLION) 60
TABLE 39 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 61
TABLE 40 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 61
TABLE 41 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 61
TABLE 42 WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 62
TABLE 43 WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 63
TABLE 44 WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 63
TABLE 45 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 64
TABLE 46 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 64
TABLE 47 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 65
TABLE 48 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 65
TABLE 49 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 65
TABLE 50 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 66
TABLE 51 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 66
TABLE 52 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 67
TABLE 53 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 67
TABLE 54 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 68
TABLE 55 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 68
TABLE 56 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 68
TABLE 57 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 69
TABLE 58 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 69
TABLE 59 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 70
TABLE 60 REST OF WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 70
TABLE 61 REST OF WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 71
TABLE 62 REST OF WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 71
TABLE 63 EASTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 72
TABLE 64 EASTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 72
TABLE 65 EASTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 73
TABLE 66 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 74
TABLE 67 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 75
TABLE 68 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 75
TABLE 69 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 76
TABLE 70 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 76
TABLE 71 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 77
TABLE 72 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 77
TABLE 73 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 78
TABLE 74 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 78
TABLE 75 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 79
TABLE 76 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 79
TABLE 77 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 80
TABLE 78 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 80
TABLE 79 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 81
TABLE 80 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 81
TABLE 81 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 82
TABLE 82 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 82
TABLE 83 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 83
TABLE 84 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 83
TABLE 85 INDONESIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 84
TABLE 86 INDONESIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 84
TABLE 87 INDONESIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 85
TABLE 88 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 85
TABLE 89 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 86
TABLE 90 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 86
TABLE 91 MIDDLE EAST AND AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2020-2027 (USD MILLION) 87
TABLE 92 MIDDLE EAST AND AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 87
TABLE 93 MIDDLE EAST AND AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 88
TABLE 94 MIDDLE EAST AND AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 88
TABLE 95 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 89
TABLE 96 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 89
TABLE 97 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 90
TABLE 98 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020-2027 (USD MILLION) 90
TABLE 99 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020-2027 (USD MILLION) 91
TABLE 100 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2020-2027 (USD MILLION) 91
TABLE 101 MAJOR MANUFACTURERS IN THE GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET 93
TABLE 102 KEY DEVELOPMENTS BY PLAYERS IN THE MARKET 94

LIST OF FIGURES

FIGURE 1 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET: MARKET STRUCTURE 15
FIGURE 2 RESEARCH PROCESS 17
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 20
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CSTD MARKET 22
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET 26
FIGURE 6 SUPPLY CHAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET 27
FIGURE 7 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020 (% SHARE) 33
FIGURE 8 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2020 & 2027 34
FIGURE 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020 (% SHARE) 37
FIGURE 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2020 & 2027 38
FIGURE 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2020 (% SHARE) 42
FIGURE 12 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2020 & 2027 42
FIGURE 13 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2020 & 2027 (USD MILLION) 46
FIGURE 14 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2020 (% SHARE) 47
FIGURE 15 AMERICAS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE, BY REGION, 2020 48
FIGURE 16 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE, BY REGION, 2020 (%) 60
FIGURE 17 WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE, BY COUNTRY, 2020 (%) 62
FIGURE 18 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE, BY COUNTRY, 2020 (%) 74
FIGURE 19 MIDDLE EAST AND AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE, BY REGION, 2020 (%) 87
FIGURE 20 CATEGORY WISE SHARE OF KEY DEVELOPMENTS 95

Product Code: MRFR/HC/6264-CR

Market Overview

The CAGR for the closed system drug transfer devices market is projected to be 19.10% until 2027. The market esteem is projected to be USD 8.95 billion by 2027.

Closed system drug transfer devices are important for specialists since they safeguard them from coincidentally being infused with hazardous drugs. These devices transfer unsafe drugs and their fumes into another system where they are entangled and can't influence individuals.

The closed system drug transfer devices market is encountering an extremely high CAGR predominantly considering the fast expansion in disease cases. As individuals live longer, they are bound to get malignant growth as they age. Additionally, many individuals smoked in their more youthful years. This can and causes different sorts of malignant growth as they age.

The closed system drug transfer devices market esteem is supposed to be USD 1.62 billion every 2027. The CAGR for this market is projected to be 20.27%. This is principally ascribed to areas of strength in a few market fragments.

The closed system drug transfer devices market has not had many restrictions. One of the primary factors that are keeping down development is the high predominance of clinical devices that either doesn't fill in as well as they ought to or don't function as they were intended to. A significant number of these devices will generally spill out hazardous and strong drugs too. At long last, openness to these drugs can make medical care laborers become fruitless rapidly.

Segment overview

The global closed system drug transfer device market is classified in terms of system, application, and end user.

The closed system drug transfer devices market can be divided into the following sub-segments based on application Nursing, Pharmacy, and Veterinary. The closed-system drug transfer devices market can be divided into the following sub-segments based on end-user Distribution channel

Regional Analysis

The North American district has the prevailing market share in the closed-system drug transfer devices market. America overwhelms as far as market share around here. The explanation is that it has a developed and mind-boggling/complex medical services system. Its emergency clinics are likewise a portion of the dominates on the planet. This country likewise burns through huge amount of cash on public and confidential medical services. It likewise has probably the best examination offices on the planet with regards to medication and clinical consideration.

The development rate in the Asia-Pacific district won't be major areas of strength for as on the grounds that the closed-system drug transfer devices market isn't vigorously controlled. Likewise, the states in most Asian countries don't focus on medical services spending, however their spending on medical services has expanded considerably lately.

Major Companies

The major players in the closed system drug transfer devices market include Becton - USA, Dickinson, and Company (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Equashield LLC (U.S.), ICU Medical Inc. (U.S.), Yukon Medical (U.S.), and Corvida Medical (U.S.)

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

1 REPORT PROLOGUE

2 MARKET INTRODUCTION

2.1 INTRODUCTION 15
2.2 ASSUMPTIONS & LIMITATIONS 15
- 2.2.1 ASSUMPTIONS 15
- 2.2.2 LIMITATIONS 15
2.3 MARKET STRUCTURE 15

3 RESEARCH METHODOLOGY

3.1 RESEARCH PROCESS 17
3.2 PRIMARY RESEARCH 18
3.3 SECONDARY RESEARCH 19
3.4 MARKET SIZE ESTIMATION 19
3.5 FORECAST MODEL 20

4 MARKET DYNAMICS

4.1 INTRODUCTION 22
4.2 DRIVERS 23
- 4.2.1 RISING PREVALENCE OF CANCER CASES 23
- 4.2.2 INCREASED RISK OF EXPOSURE TO HAZARDOUS DRUGS FOR HEALTHCARE PERSONNEL 23
- 4.2.3 SEVERAL SAFETY GUIDELINES AND LEGISLATION FOR THE USE OF CSTD 23
4.3 RESTRAINTS 24
- 4.3.1 HIGH COST 24
- 4.3.2 ADVERSE EVENTS AND STATUTORY WARNING BY FDA FOR THE USE OF CSTD 24
4.4 OPPORTUNITY 24
- 4.4.1 EMERGING MARKETS OF CSTD 24

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES ANALYSIS 26
- 5.1.1 BARGAINING POWER OF SUPPLIERS 26
- 5.1.2 BARGAINING POWER OF BUYERS 27
- 5.1.3 THREAT OF NEW ENTRANTS 27
- 5.1.4 THREAT OF SUBSTITUTES 27
- 5.1.5 INTENSITY OF RIVALRY 27
5.2 SUPPLY CHAIN ANALYSIS 27
- 5.2.1 R&D 28
- 5.2.2 MANUFACTURING 28
- 5.2.3 DISTRIBUTION 28
- 5.2.4 MARKETING & SALES 28
- 5.2.5 POST-SALES MONITORING 28
5.3 INVESTMENT OPPORTUNITIES 28
5.4 PRICING ANALYSIS 29
5.5 MARKETING CHANNEL 29
- 5.5.1 DIRECT MARKETING 29
- 5.5.2 INDIRECT MARKETING 29
5.6 REGULATORY AFFAIRS 29
5.7 COST OF PRODUCTION ANALYSIS 30
- 5.7.1 RAW MATERIAL COST ANALYSIS 31
- 5.7.2 TECHNOLOGY COST ANALYSIS 31
- 5.7.3 LABOR COST ANALYSIS 31

6 CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE

6.1 OVERVIEW 33
- 6.1.1 INTRODUCTION 33
- 6.1.2 BARRIER-TYPE 35
- 6.1.3 FILTRATION-TYPE 35

7 CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY

7.1 OVERVIEW 37
- 7.1.1 INTRODUCTION 37
- 7.1.2 CLOSED BAG/LINE ACCESS DEVICES 39
- 7.1.3 CLOSED VIAL ACCESS DEVICES 39
- 7.1.4 CLOSED SYRINGE SAFETY DEVICES 40